Clinical Trials in San Antonio

Showing 7501-7520 of 11,125 trials

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

NCT02138812

Determine the safety, tolerability, maximum tolerated dose (MTD), and recommended Phase II dose (RP2D) of BAY1161909 in combination with paclitaxel in subjects with advanced malignancies.

Medical Oncology

Bayer69 participantsStarted May 2014

Santa Monica, California, United States • New Haven, Connecticut, United States • Boston, Massachusetts, United States +3 more locations

COMPLETEDNA< 1 mile

Optimizing Vitamin D Status During Initial Military Training

NCT01617109

The primary objective of this randomized, double-blind, placebo-controlled trial is to determine the effect of vitamin D and calcium supplementation (800IU and 2000mg, respectively) on biochemical indicators of nutritional status and bone health in military personnel during Army basic combat training (BCT) and Air Force basic military training (BMT). The investigators hypothesize that daily supplementation with vitamin D and calcium during military training will improve vitamin D status, stabilize PTH levels, and result in improvements in markers of bone health. As a result of the investigators study design, the findings will provide critically important data regarding the concentration of vitamin D in blood necessary to stabilize PTH levels and to optimize bone formation during initial military training.

Bone HealthNutrition Status

United States Army Research Institute of Environmental Medicine342 participantsStarted Jun 2012

Fort Sill, Oklahoma, United States • San Antonio, Texas, United States

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

Optimizing Vitamin D Status During Initial Military Training

Find Trials by Condition in San Antonio

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Medical Therapy of Prostatic Symptoms

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Phase II Combination Steroid and Anti-VEGF for Persistent DME

A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Multicenter Continuous Peripheral Nerve Block Surveillance Study

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

Sevelamer for Reducing Endotoxemia and Immune Activation

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma